LMWH conjugate LHT7 has inhibited VEGF-dependent phosphorylation in MDA-MB-231 breast cancer cells [50]; LHT7 has also been shown to block other factors such as fibroblast growth factor 2 (FGF2) and platelet-derived growth factor B (PDGF-B) [51]. Here, FGF2 is linked to breast carcinoma.